Notable Labs, Ltd. – NASDAQ:NTBL
Notable Labs, Ltd. stock price today
Notable Labs, Ltd. stock price monthly change
Notable Labs, Ltd. key metrics
Market Cap | 2.39M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -3.63 |
Revenue | N/A |
EBITDA | -10.86M |
Income | -10.55M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNotable Labs, Ltd. stock price history
Notable Labs, Ltd. stock forecast
Notable Labs, Ltd. financial statements
| Dec 2022 | 0 | -3.27M | |
|---|---|---|---|
| Mar 2023 | 0 | -2.63M | |
| Jun 2023 | 0 | -874K | |
| Mar 2024 | 1K | -3.76M | -376600% |
| Jun 2023 | 0 | -874K | |
|---|---|---|---|
| Mar 2024 | 1K | -3.76M | -376600% |
| Sep 2025 | 991 | -6.58M | -664311.91% |
| Dec 2025 | 990 | -7.12M | -719638.99% |
Analysts Price target
Financials & Ratios estimates
| Mar 2024 | 15598000 | 4.05M | 25.98% |
|---|
| Dec 2022 | -6.30M | 5.62M | -149 |
|---|---|---|---|
| Mar 2023 | -1.68M | 10.1M | 4.34M |
| Jun 2023 | -2.29M | 20.70K | 983 |
| Mar 2024 | -3.56M | -6K | -19K |
Notable Labs, Ltd. alternative data
| Jun 2024 | 16 |
|---|---|
| Jul 2024 | 16 |
Notable Labs, Ltd. other data
Thursday, 29 August 2024 | ||
| Notable Labs to Present Data on September 4th at SOHO 2024 | globenewswire.com | |
Monday, 26 August 2024 | ||
| Notable Labs Announces CEO Transition | globenewswire.com | |
Friday, 24 May 2024 | ||
| Bears are Losing Control Over Notable Labs (NTBL), Here's Why It's a 'Buy' Now | zacks.com | |
Thursday, 9 May 2024 | ||
| Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024 | globenewswire.com |
-
What's the price of Notable Labs, Ltd. stock today?
One share of Notable Labs, Ltd. stock can currently be purchased for approximately $0.25.
-
When is Notable Labs, Ltd.'s next earnings date?
Unfortunately, Notable Labs, Ltd.'s (NTBL) next earnings date is currently unknown.
-
Does Notable Labs, Ltd. pay dividends?
No, Notable Labs, Ltd. does not pay dividends.
-
How much money does Notable Labs, Ltd. make?
Notable Labs, Ltd. has a market capitalization of 2.39M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3775% to 310K US dollars.
-
What is Notable Labs, Ltd.'s stock symbol?
Notable Labs, Ltd. is traded on the NASDAQ under the ticker symbol "NTBL".
-
What is Notable Labs, Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Notable Labs, Ltd.?
Shares of Notable Labs, Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Notable Labs, Ltd. have?
As Jul 2024, Notable Labs, Ltd. employs 16 workers.
-
When Notable Labs, Ltd. went public?
Notable Labs, Ltd. is publicly traded company for more then 10 years since IPO on 1 Oct 2014.
-
What is Notable Labs, Ltd.'s official website?
The official website for Notable Labs, Ltd. is notablelabs.com.
-
Where are Notable Labs, Ltd.'s headquarters?
Notable Labs, Ltd. is headquartered at 320 Hatch Drive, Foster City, CA.
-
How can i contact Notable Labs, Ltd.?
Notable Labs, Ltd.'s mailing address is 320 Hatch Drive, Foster City, CA and company can be reached via phone at +41 58512410.
Notable Labs, Ltd. company profile:
Notable Labs, Ltd.
notablelabs.comNASDAQ
16
Biotechnology
Healthcare
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
Foster City, CA 94404
CIK: 0001603207
ISIN: IL0012002452
:
